A Multicentre, Non-interventional, Prospective, Observational Drug Utilisation Study of Ayendi Nasal Spray Prescribed as Treatment in Emergency Departments in the United Kingdom (UK) (DIAPASS)

14/10/2016
12/11/2019
EU PAS number:
EUPAS15371
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

DIA003_DIAPASS Protocol_V3.0 23-11-2016_signed

English (2.28 MB - PDF) View document
Study results
Study results

Summary of DIA003_DIAPASS_Final_Clinical Study Report v1.0 04-11-19

English (105.95 KB - PDF) View document
Study report
Other information
Study, other information

Ayendi PASS AR 04082016

English (609.29 KB - PDF) View document